Radiation Modulates HER2 Expression and Trastuzumab Deruxtecan Response in HER2-Low Metastatic Breast Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S294
DOI: 10.1016/j.ijrobp.2026.06.620 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Q. Li und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, Q., Rather, G., Nwachukwu, T., Speers, C., Perlow, H., Vempati, P., Haffty, B., & Miller, T. (2026). Radiation Modulates HER2 Expression and Trastuzumab Deruxtecan Response in HER2-Low Metastatic Breast Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), S294. https://doi.org/10.1016/j.ijrobp.2026.06.620
Vancouver
Li Q, Rather G, Nwachukwu T, Speers C, Perlow H, Vempati P, et al. Radiation Modulates HER2 Expression and Trastuzumab Deruxtecan Response in HER2-Low Metastatic Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S294. doi:10.1016/j.ijrobp.2026.06.620
BibTeX
@article{Li2026,
author = {Li, Q. and Rather, G. and Nwachukwu, T. and Speers, C. and Perlow, H.K. and Vempati, P. and Haffty, B.G. and Miller, T.},
title = {Radiation Modulates HER2 Expression and Trastuzumab Deruxtecan Response in HER2-Low Metastatic Breast Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S294},
doi = {10.1016/j.ijrobp.2026.06.620}
}
EUVIMED